We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

21 hedge funds and large institutions have $4.21M invested in Zomedica Corp. in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% less capital invested

Capital invested by funds: $4.8M → $4.21M (-$584K)

16% less funds holding

Funds holding: 25 → 21 (-4)

57% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 7

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
21
Holders Change
-4
Holders Change %
-16%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$8.92K
2
IP
Isthmus Partners
Wisconsin
+$7.47K
3
AG
Advisor Group
Arizona
+$336
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$132

Top Sellers

Rank Fund Capital Flow
1
LP
LMR Partners
United Kingdom
-$18K
2
Renaissance Technologies
Renaissance Technologies
New York
-$13K
3
UBS Group
UBS Group
Switzerland
-$12.3K
4
Millennium Management
Millennium Management
New York
-$11K
5
Jane Street
Jane Street
New York
-$7K

ZOM Hedge Fund Activity: Q4 2019 in Review

21 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2019, worth a combined $4.21M — down 12% from $4.8M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ZOM and 2 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 3 added.

The largest buyer was Citadel Advisors, adding an estimated $8.92K. The largest seller was LMR Partners, exiting entirely with an estimated $18K sold.

  • 21 institutional investors held Zomedica Corp. (ZOM) as of Q4 2019, down from 25 in Q3 2019.
  • Funds reported $4.21M of Zomedica Corp. stock for Q4 2019, down 12% quarter-over-quarter.
  • 2 funds opened new Zomedica Corp. positions in Q4 2019 and 6 closed out, a net change of -4 holders.
  • The largest Zomedica Corp. buyer in Q4 2019 was Citadel Advisors, an estimated $8.92K added.
  • The largest Zomedica Corp. seller in Q4 2019 was LMR Partners, an estimated $18K sold.

Based on aggregated 13F filings for Q4 2019.